• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人干扰素在兔、猴和小鼠体内外源性给药后的组织分布。

Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.

作者信息

Billiau A, Heremans H, Ververken D, van Damme J, Carton H, de Somer P

出版信息

Arch Virol. 1981;68(1):19-25. doi: 10.1007/BF01315163.

DOI:10.1007/BF01315163
PMID:6166278
Abstract

Preparations of human leukocyte (alpha) and fibroblast (beta) interferon were given intramuscularly to rabbits and monkeys, and circulating interferon was measured. In rabbits, but not in monkeys, a marked difference between the two interferons was noted in that higher titers of circulating antiviral activity were obtained with leukocyte than with fibroblast interferon. In mice, injected interperitoneally, a similar difference could be noted. However, levels of antiviral activity in homogenates of spleens and lungs did not differ between mice injected with either interferon. Fibroblast interferon that was injected intrathecally in monkeys was found to diffuse throughout the cerebrospinal canal and to reach the serum compartment. Some interferon could also be recovered from the pia mater surrounding the brain hemispheres, but none was found in the deeper layers of the brain.

摘要

将人白细胞(α)干扰素制剂和成纤维细胞(β)干扰素制剂分别肌肉注射给兔子和猴子,并检测循环中的干扰素。在兔子而非猴子中,发现两种干扰素存在显著差异,即白细胞干扰素比成纤维细胞干扰素产生更高的循环抗病毒活性滴度。在经腹腔注射的小鼠中也可观察到类似差异。然而,注射了任一干扰素的小鼠,其脾脏和肺匀浆中的抗病毒活性水平并无差异。在猴子中鞘内注射的成纤维细胞干扰素可扩散至整个脑脊管并进入血清区室。在大脑半球周围的软脑膜中也可回收一些干扰素,但在大脑深层未发现。

相似文献

1
Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.人干扰素在兔、猴和小鼠体内外源性给药后的组织分布。
Arch Virol. 1981;68(1):19-25. doi: 10.1007/BF01315163.
2
Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.兔循环系统中人类成纤维细胞干扰素和白细胞干扰素清除率的比较。
J Infect Dis. 1976 Jun;133 Suppl:A18-21. doi: 10.1093/infdis/133.supplement_2.a18.
3
Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.人成纤维细胞和白细胞干扰素在兔体内的药代动力学特性。
J Clin Microbiol. 1980 Jan;11(1):102-5. doi: 10.1128/jcm.11.1.102-105.1980.
4
Pharmacokinetics of human interferon-beta in monkeys.人β干扰素在猴子体内的药代动力学
J Interferon Res. 1981;1(3):427-36. doi: 10.1089/jir.1981.1.427.
5
Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.人白细胞干扰素和成纤维细胞干扰素对恒河猴牛痘损伤的预防作用
J Gen Virol. 1980 May;48(1):25-30. doi: 10.1099/0022-1317-48-1-25.
6
[Distribution of human interferon in organs and tissues after its administration to man and animals].[人用干扰素给药后在人和动物体内各器官和组织中的分布]
Vopr Virusol. 1980 Sep-Oct(5):594-6.
7
Interferon crosses blood-cerebrospinal fluid barrier in monkeys.干扰素可穿过猴子的血脑脊髓液屏障。
Proc Soc Exp Biol Med. 1975 May;149(1):287-9. doi: 10.3181/00379727-149-38790.
8
Neutralizing antibodies against human leukocyte, lymphoblastoid and fibroblast interferons elicited by immunization with human leukocyte interferon.用人白细胞干扰素免疫引发的针对人白细胞、淋巴母细胞和成纤维细胞干扰素的中和抗体。
Acta Pathol Microbiol Scand C. 1978 Dec;86C(6):291-8. doi: 10.1111/j.1699-0463.1978.tb02593.x.
9
Enzymatic modifications of human fibroblast and leukocyte interferons.人成纤维细胞干扰素和白细胞干扰素的酶促修饰
J Virol. 1980 Aug;35(2):390-9. doi: 10.1128/JVI.35.2.390-399.1980.
10
Circulating interferon in man after administration of exogenous human leukocyte interferon.给予外源性人白细胞干扰素后人体循环中的干扰素
J Natl Cancer Inst. 1975 May;54(5):1045-9.

引用本文的文献

1
A Historical Review of Brain Drug Delivery.脑药物递送的历史回顾
Pharmaceutics. 2022 Jun 16;14(6):1283. doi: 10.3390/pharmaceutics14061283.
2
Computational model of brain endothelial cell signaling pathways predicts therapeutic targets for cerebral pathologies.脑内皮细胞信号通路的计算模型预测了脑病理学的治疗靶点。
J Mol Cell Cardiol. 2022 Mar;164:17-28. doi: 10.1016/j.yjmcc.2021.11.005. Epub 2021 Nov 16.
3
Quantitative systems pharmacology of interferon alpha administration: A multi-scale approach.干扰素 α 给药的定量系统药理学:多尺度方法。

本文引用的文献

1
Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.人成纤维细胞和白细胞干扰素在兔体内的药代动力学特性。
J Clin Microbiol. 1980 Jan;11(1):102-5. doi: 10.1128/jcm.11.1.102-105.1980.
2
Interferon in experimental viral infections in mice: tissue interferon levels resulting from the virus infection and from exogenous interferon therapy.干扰素在小鼠实验性病毒感染中的作用:病毒感染及外源性干扰素治疗所导致的组织干扰素水平
Infect Immun. 1980 Nov;30(2):513-22. doi: 10.1128/iai.30.2.513-522.1980.
3
Interferon crosses blood-cerebrospinal fluid barrier in monkeys.
PLoS One. 2019 Feb 13;14(2):e0209587. doi: 10.1371/journal.pone.0209587. eCollection 2019.
4
Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.中枢神经系统疾病的被动免疫疗法:当前的传递挑战和新方法。
Bioconjug Chem. 2018 Dec 19;29(12):3937-3966. doi: 10.1021/acs.bioconjchem.8b00548. Epub 2018 Oct 24.
5
Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities.神经认知疾病中 microRNA 表达的药物调节:障碍与未来机遇。
Curr Neuropharmacol. 2017;15(2):276-290. doi: 10.2174/1570159x14666160630210422.
6
Drug transport in brain via the cerebrospinal fluid.脑内药物经脑脊液转运。
Fluids Barriers CNS. 2011 Jan 18;8(1):7. doi: 10.1186/2045-8118-8-7.
7
Behavioral evaluation of transgenic mice with CNS expression of IFN-alpha by elevated plus-maze and Porsolt swim test.通过高架十字迷宫和强迫游泳试验对 CNS 表达 IFN-α 的转基因小鼠进行行为评估。
Neurosci Lett. 2010 Aug 2;479(3):287-91. doi: 10.1016/j.neulet.2010.05.082. Epub 2010 Jun 4.
8
Nanotechnology for delivery of drugs to the brain for epilepsy.用于将药物递送至脑部以治疗癫痫的纳米技术。
Neurotherapeutics. 2009 Apr;6(2):323-36. doi: 10.1016/j.nurt.2009.01.018.
9
Systemic interferon-alpha regulates interferon-stimulated genes in the central nervous system.全身性干扰素-α调节中枢神经系统中的干扰素刺激基因。
Mol Psychiatry. 2008 Mar;13(3):293-301. doi: 10.1038/sj.mp.4002013. Epub 2007 May 8.
10
The blood-brain barrier: bottleneck in brain drug development.血脑屏障:脑药物研发的瓶颈
NeuroRx. 2005 Jan;2(1):3-14. doi: 10.1602/neurorx.2.1.3.
干扰素可穿过猴子的血脑脊髓液屏障。
Proc Soc Exp Biol Med. 1975 May;149(1):287-9. doi: 10.3181/00379727-149-38790.
4
Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.用于临床试验的人成纤维细胞干扰素:实验动物和人类的药代动力学及耐受性
Antimicrob Agents Chemother. 1979 Jul;16(1):56-63. doi: 10.1128/AAC.16.1.56.
5
Human fibroblast interferon for clinical trials: production, partial purification, and characterization.用于临床试验的人成纤维细胞干扰素:生产、部分纯化及特性鉴定
Antimicrob Agents Chemother. 1979 Jul;16(1):49-55. doi: 10.1128/AAC.16.1.49.
6
Non-appearance of injected fibroblast interferon in circulation.循环中未出现注射的成纤维细胞干扰素。
Lancet. 1978 Feb 25;1(8061):451-2. doi: 10.1016/s0140-6736(78)91251-5.